Learn about Parkinson's Disease Awareness Month, Terry Crews' wife's battle, and a new treatment option called focused ...

The launch of a new national research collaboration focused on Parkinson’s disease has been announced. The Parkinson’s ...

Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most ...

Lab-grown dopamine cells show early success in Parkinson’s patients, improving movement and offering a new treatment path.

A new nasal spray treatment being developed by FIU researchers could slow Parkinson's disease progression, offering hope for a major shift beyond symptom management.

About 90,000 Americans are expected to be diagnosed with Parkinson’s disease this year. Researchers say early deep brain stimulation and new therapies may help slow progression. TULSA, Okla. - About ...

Returning or worsening Parkinson’s symptoms may indicate that your current medication isn’t working as well, signaling a need to consider switching or adjusting your treatment plan. In advanced stages ...

Up to one in three people with Parkinson's disease use at least one psychotropic medication, a recent study from the ...

Globally, Parkinson's has a global disease burden that is expected to double by 2050, with cases rising from 8.5 million in 2021 to 17.5 million. These figures have been highlighted in the study ...

AI‑designed intracellular antibody fragments can stay stable inside cells and bind misfolded proteins, opening new treatment ...

As Parkinson’s Awareness Month comes to a close, the urgency to challenge the status quo has never been greater. With nearly ...